AlphaStocks
5.1
Consider Buy

CHEMED CORP (CHE)

Health Care / Health Care Services

S&P MidCap 400

$489.53

Below average on several measures. Research carefully.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#523out of 1121 in Health Care

Is CHEMED CORP a Good Investment in 2026?

CHEMED CORP (CHE) scores 5.1 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates CHEMED CORP as Attractive (5/9). However, the Lynch model rates it Caution — PEG 1.4 · Fast Grower. CHEMED CORP currently trades below its estimated fair value of $551, suggesting potential upside. CHEMED CORP ranks #523 out of 1121 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E20.9ROE-9.6Market Cap7B

Estimated Fair Value

$550.6611% below

Trading near or slightly below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Caution

PEG 1.4 · Fast Grower

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is CHEMED CORP (CHE) a good investment?
Based on AlphaStocks' composite analysis, CHEMED CORP (CHE) scores 5.1 out of 10, earning a Consider Buy rating. This score is below average, suggesting caution. Trading near or slightly below estimated fair value.
What is CHEMED CORP's Piotroski F-Score?
CHEMED CORP's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is CHE overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $551, CHE appears undervalued. The stock currently trades 11% below its estimated fair value. Trading near or slightly below estimated fair value.
How does CHE compare to other Health Care stocks?
CHEMED CORP ranks #523 out of 1121 stocks in the Health Care sector, placing it in the top 47% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about CHE?
AlphaStocks evaluates CHE using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Neutral; Lynch: Caution. These models are combined into a single composite score of 5.1/10.

Similar Stocks

PARRBFAMAZN

Compare CHE with

CHE vs PARRCHE vs BFAMCHE vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer